A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo

DNA origami-based nanorobot presents thrombin to cause tumor infarction after specific recognition of a tumor vessel marker. Nanoscale robots have potential as intelligent drug delivery systems that respond to molecular triggers 1 , 2 , 3 , 4 . Using DNA origami we constructed an autonomous DNA robo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature biotechnology Jg. 36; H. 3; S. 258 - 264
Hauptverfasser: Li, Suping, Jiang, Qiao, Liu, Shaoli, Zhang, Yinlong, Tian, Yanhua, Song, Chen, Wang, Jing, Zou, Yiguo, Anderson, Gregory J, Han, Jing-Yan, Chang, Yung, Liu, Yan, Zhang, Chen, Chen, Liang, Zhou, Guangbiao, Nie, Guangjun, Yan, Hao, Ding, Baoquan, Zhao, Yuliang
Format: Journal Article
Sprache:Englisch
Veröffentlicht: New York Nature Publishing Group US 01.03.2018
Nature Publishing Group
Schlagworte:
ISSN:1087-0156, 1546-1696, 1546-1696
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:DNA origami-based nanorobot presents thrombin to cause tumor infarction after specific recognition of a tumor vessel marker. Nanoscale robots have potential as intelligent drug delivery systems that respond to molecular triggers 1 , 2 , 3 , 4 . Using DNA origami we constructed an autonomous DNA robot programmed to transport payloads and present them specifically in tumors. Our nanorobot is functionalized on the outside with a DNA aptamer that binds nucleolin, a protein specifically expressed on tumor-associated endothelial cells 5 , and the blood coagulation protease thrombin within its inner cavity. The nucleolin-targeting aptamer serves both as a targeting domain and as a molecular trigger for the mechanical opening of the DNA nanorobot. The thrombin inside is thus exposed and activates coagulation at the tumor site. Using tumor-bearing mouse models, we demonstrate that intravenously injected DNA nanorobots deliver thrombin specifically to tumor-associated blood vessels and induce intravascular thrombosis, resulting in tumor necrosis and inhibition of tumor growth. The nanorobot proved safe and immunologically inert in mice and Bama miniature pigs. Our data show that DNA nanorobots represent a promising strategy for precise drug delivery in cancer therapy.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1087-0156
1546-1696
1546-1696
DOI:10.1038/nbt.4071